PCOS, High Prolactin & Ovarian Insufficiency

PCOS has become the catch-all diagnosis for almost any woman with irregular cycles, missing periods, or difficulty getting pregnant. A doctor orders a basic blood panel, finds something slightly off, sees a few follicles on an ultrasound, and hands over a PCOS diagnosis — often with a prescription for the pill and little else. The problem? PCOS is a diagnosis of exclusion. Before it can be legitimately confirmed, several other conditions that produce nearly identical symptoms must be ruled out first.

Two of the most commonly missed are hyperprolactinemia (chronically elevated prolactin) and primary ovarian insufficiency (POI). All three conditions can cause irregular or absent periods, disrupted ovulation, and fertility challenges. But their underlying mechanisms are completely different — and so are their treatment approaches. Treating hyperprolactinemia like PCOS, or assuming POI is just "irregular cycles," can delay recovery by years and leave the real problem unaddressed.

This article breaks down exactly what each condition is, how they differ, what to test for, and how to advocate for yourself in a medical system that too often stops at the first plausible-sounding diagnosis.

PCOS: What It Actually Is

Polycystic ovary syndrome is the most common endocrine-metabolic disorder in women of reproductive age and the leading cause of ovulatory infertility. But as its name suggests, it is a syndrome — a cluster of symptoms, not a single disease with a single cause. This distinction matters enormously, because it means the same diagnosis can describe very different underlying conditions in different people.

The Rotterdam Criteria

The standard diagnostic framework — the Rotterdam criteria — requires that a person present with at least two of the following three features:

• Irregular or absent ovulation — cycles that are consistently longer than 35 days, unpredictable, or entirely absent
• Clinical or biochemical hyperandrogenism — elevated androgens (testosterone, DHEA-S, androstenedione) on labs, or visible signs like excess facial hair (hirsutism), acne, or male-pattern hair thinning
• Polycystic ovaries on ultrasound — enlarged ovaries containing multiple small follicles (technically antral follicles that have arrested before reaching ovulation, not true cysts)

It's worth noting that about 20% of women without PCOS have polycystic-appearing ovaries on ultrasound, and roughly 30% of women with PCOS do not. This is one reason the ultrasound finding alone is never sufficient for diagnosis — and why discussions about renaming the condition entirely are ongoing. The most recent proposed name is Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome, which more accurately reflects the core issue.

The Four Root-Cause Types

Within the PCOS umbrella, four functionally distinct types are commonly identified, and each calls for a different strategy:

• Insulin-resistant PCOS — by far the most prevalent, affecting 65-70% of people with the condition. Elevated insulin drives the ovaries to produce excess androgens, suppresses sex hormone-binding globulin (SHBG), and creates a self-reinforcing cycle of androgen excess and metabolic dysfunction.
• Inflammatory PCOS — chronic low-grade inflammation is both a driver and a consequence of PCOS. Oxidative stress in the follicular fluid impairs egg quality and disrupts the ovulatory process. Blood sugar and gut health are typically at the root.
• Post-pill PCOS — some people experience temporary hyperandrogenism and cycle disruption after stopping hormonal birth control, as the suppression lifts and the HPO axis works to reestablish its rhythm. This is usually time-limited but can persist in those with underlying susceptibility.
• Adrenal PCOS — in 20-30% of PCOS cases, elevated DHEA-S (rather than ovarian testosterone) is the primary androgenic driver. This type is closely linked to HPA axis dysregulation and chronic stress.

Key Symptoms and Common Misconceptions

Classic signs of androgen excess in PCOS include irregular or absent periods, acne, hirsutism, hair thinning at the temples and crown, and difficulty losing weight despite dietary changes. What often surprises people is that women with PCOS tend to have lower estrogen levels overall — not higher. The common belief that PCOS equals estrogen dominance is misleading. What is often observed is a relative estrogen dominance in relation to chronically low progesterone, since without consistent ovulation, the corpus luteum never forms and progesterone output stays minimal.

Critically, PCOS is a diagnosis of exclusion. The conditions that must be ruled out first include congenital adrenal hyperplasia, hypothalamic amenorrhea, hypothyroidism — and both hyperprolactinemia and primary ovarian insufficiency, which we'll cover in detail below.

High Prolactin: The Frequently Missed Diagnosis

Prolactin is the hormone best known for stimulating milk production after childbirth. But it is always present in the body, and when its levels climb too high outside of pregnancy and breastfeeding — a condition called hyperprolactinemia — it becomes a potent suppressor of ovulation and a significant driver of cycle disruption.

How Elevated Prolactin Shuts Down Your Cycle

Prolactin exerts its suppressive effect by inhibiting GnRH (gonadotropin-releasing hormone) from the hypothalamus. GnRH is the master signal that triggers the entire HPO axis — it prompts the pituitary to release FSH and LH, which in turn drive follicle development and the LH surge that triggers ovulation. When prolactin is elevated, this entire chain reaction is interrupted at its source. The result is diminished FSH, absent or blunted LH surge, poor follicle development, and suppressed or absent ovulation.

What Causes Prolactin to Rise

Prolactin levels can climb for a range of reasons, some structural and some functional:

• Pituitary adenoma (prolactinoma) — a benign tumor of the pituitary gland is the most common structural cause of elevated prolactin. It is usually small (microprolactinoma) and highly treatable, but requires proper imaging to detect.
• Hypothyroidism — this is a critical and often missed link. When the thyroid is underactive, the hypothalamus releases more TRH (thyrotropin-releasing hormone) to stimulate the pituitary to make more TSH. TRH also stimulates prolactin release as a side effect, which is why untreated hypothyroidism can cause elevated prolactin even in the absence of a pituitary tumor.
• Medications — antidepressants (SSRIs and tricyclics), antipsychotics, metoclopramide (a nausea medication), and certain blood pressure medications (like verapamil) all raise prolactin as a known side effect. This is rarely discussed with patients when these medications are prescribed.
• Chronic stress — the HPA axis and the HPO axis are deeply interconnected. Sustained elevated cortisol can alter prolactin regulation and contribute to mild hyperprolactinemia.
• Nipple stimulation — physical stimulation of the nipples triggers a physiological prolactin response. Excessive or frequent stimulation outside of breastfeeding can contribute to mildly elevated levels.
• Intense exercise — acute prolactin spikes occur with vigorous exercise. In athletes with very high training loads, this can contribute to cycle disruption alongside the other hormonal effects of overtraining.

Symptoms That Overlap With PCOS

This is where hyperprolactinemia becomes easy to miss. The symptoms overlap significantly with PCOS:

• Irregular or absent periods
• Anovulation (absent ovulation) and fertility challenges
• Vaginal dryness and low libido (from suppressed estrogen)
• Headaches or visual disturbances (if a larger pituitary tumor is involved)
• Galactorrhea — spontaneous milk discharge from the nipples in a woman who is not pregnant or breastfeeding. This symptom is highly specific to hyperprolactinemia and is rarely seen in PCOS. If you experience this, request prolactin testing immediately.

Testing and Treatment

Testing is straightforward: a fasting morning prolactin blood test. Levels above roughly 25 ng/mL warrant investigation, though labs vary. One elevated reading should be confirmed with a second test, as prolactin is acutely sensitive to stress, sex, and eating — ideally, blood should be drawn in a calm state, mid-morning, after the person has been sitting quietly for at least 20 minutes. If prolactin is consistently elevated, an MRI of the pituitary is the next step to rule out an adenoma.

Treatment depends on the cause. If a prolactinoma is identified, dopamine agonists like cabergoline or bromocriptine are first-line medical treatment and are highly effective. If the elevation is medication-induced, working with the prescribing physician to explore alternatives is appropriate. If hypothyroidism is driving the elevated prolactin, addressing the thyroid often normalizes prolactin on its own — which is why a thorough thyroid panel should always be part of a workup for cycle irregularity.

Primary Ovarian Insufficiency: Not Premature Menopause

Primary ovarian insufficiency (POI) is perhaps the most serious and least understood of the three conditions covered here. It was previously called premature ovarian failure or premature menopause, but those terms are both inaccurate and unnecessarily distressing. POI does not mean the ovaries have completely and permanently stopped — some women with POI still ovulate occasionally and even conceive naturally. What it does mean is that the ovaries are functioning below capacity for a woman's age, with a declining or severely diminished follicle reserve.

What POI Actually Is

POI is defined as cessation or marked reduction of normal ovarian function before age 40, associated with elevated FSH (typically above 25-40 IU/L on two separate tests at least a month apart). Because the ovaries are no longer responding adequately to FSH signals from the pituitary, the pituitary responds by producing more and more FSH in an attempt to stimulate the ovaries — which is why elevated FSH is the diagnostic hallmark. LH is often elevated as well.

The distinction from PCOS is important: in PCOS, FSH is typically normal or low, LH is often elevated relative to FSH, and the issue is not follicle depletion but rather follicle arrest (follicles are present in abundance but aren't maturing to ovulation). In POI, follicles are genuinely depleted or non-responsive — the reserve is running out prematurely.

Causes

In many cases — roughly 90% — no specific cause is identified (idiopathic POI). In the remaining cases, known causes include:

• Autoimmune — about 30% of people with POI have a coexisting autoimmune condition. The most common are Hashimoto's thyroiditis, Type 1 diabetes, and adrenal insufficiency (Addison's disease), as well as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease. The immune system may be producing antibodies that attack ovarian tissue directly.
• Genetic — Fragile X syndrome (the most common inherited cause of POI), Turner syndrome (a chromosomal condition involving one intact X chromosome), and various other chromosomal anomalies have been associated with POI.
• Iatrogenic — chemotherapy and pelvic radiation can cause irreversible ovarian damage and POI. The younger the person at the time of treatment, the greater the risk, which is why fertility preservation before cancer treatment is increasingly offered.
• Environmental — emerging research links exposure to certain endocrine-disrupting chemicals — bisphenol A, polychlorinated biphenyls, pesticides, and cigarette smoke — to accelerated follicle depletion and POI risk.

Symptoms, Testing, and Options

POI symptoms include irregular or absent periods, hot flashes and night sweats, vaginal dryness, difficulty concentrating, mood changes, and reduced libido — many of which overlap with perimenopause symptoms, because the underlying mechanism (declining estrogen) is similar. Some women with POI still have apparently regular periods but have silently rising FSH and declining ovarian reserve; this is why symptoms alone are an unreliable guide.

Testing should include FSH and LH (elevated), estradiol (usually low), and AMH (anti-Müllerian hormone), which reflects the size of the remaining follicle pool and is often very low in POI. A full thyroid panel and screening for autoimmune markers are also appropriate given the strong autoimmune association. Karyotyping may be recommended, especially in younger women.

There is no treatment that restores the original follicle pool. However, POI is not the same as menopause: some women with POI do conceive naturally, particularly in the early stages of the condition. Egg donation is the most reliable path to pregnancy for those who have not been able to conceive naturally. Hormone replacement therapy is recommended for most women with POI under 50, both for bone density and cardiovascular protection, since the early loss of estrogen and progesterone carries long-term health risks.

Why Getting the Right Diagnosis Matters

These three conditions share surface-level symptoms but have entirely different biological drivers. The treatment approach that helps one can actively harm another. Vitex and PCOS caution is a good example: vitex (chasteberry) is sometimes used to support progesterone and regulate cycles, but it primarily works by modulating prolactin — which means it is contraindicated in women who already have suppressed prolactin levels from POI, and using it without knowing your diagnosis could worsen your situation. Similarly, aggressive insulin-sensitizing protocols appropriate for insulin-resistant PCOS are completely irrelevant for POI or for someone whose cycle disruption is caused by a prolactinoma.

Getting the right diagnosis also determines urgency. POI carries implications for long-term bone, cardiovascular, and neurological health that require proactive management. A prolactinoma that is left undetected and untreated can grow and compress nearby structures. These are not conditions where watchful waiting and lifestyle changes alone are appropriate — they require proper medical workup and, in many cases, medical treatment alongside any lifestyle support.

How to Advocate for Proper Lab Testing

If you have irregular or absent periods, missed ovulation, fertility challenges, or any of the symptoms described above, these are the tests worth asking for:

• FSH and LH — tested on day 2-3 of your cycle (or at any time if your cycles are absent). Elevated FSH with irregular cycles is a red flag for POI. In PCOS, LH is often disproportionately elevated relative to FSH.
• Prolactin — fasting, mid-morning, confirmed with a second test if elevated. Essential for ruling out hyperprolactinemia before any PCOS diagnosis is confirmed.
• AMH (anti-Müllerian hormone) — can be tested at any point in the cycle and is the most reliable marker of ovarian reserve. Very low AMH alongside elevated FSH strongly suggests POI.
• Full thyroid panel — TSH alone is not enough. Request Free T3, Free T4, Reverse T3, and thyroid antibodies (TPO and TgAb). Hypothyroidism can drive elevated prolactin, worsen PCOS symptoms, and impair follicle development independently.
• Total and free testosterone, DHEA-S, androstenedione — to confirm the presence and source (ovarian vs. adrenal) of androgen excess in suspected PCOS.
• Fasting insulin and glucose (HOMA-IR) — to assess insulin resistance, especially relevant in PCOS.
• Estradiol — low estradiol with elevated FSH/LH points toward POI; in PCOS estradiol is often within normal range but may be relatively low.

You have every right to request these tests and to ask for a second opinion if your concerns are dismissed. Bringing a list of specific tests to your appointment, citing symptoms clearly, and asking "what conditions are being ruled out before this diagnosis is confirmed?" are all effective ways to advocate for thorough care.